Profhilo vs Sunekos. A practitioner comparison.

Both Profhilo and Sunekos 200 are positioned as bio-stimulators, both ship in 2ml-class formats, and both target skin quality rather than volumising. Beyond that, the mechanism, protocol and indication differ materially. This is the comparison most aesthetic-clinic owners need before deciding stock-mix.

Mechanism

Profhilo is hybrid hyaluronic acid (high and low molecular weight HA cross-linked) by IBSA. The active mechanism is HA-driven hydration plus a bio-remodelling effect on collagen and elastin. Five-bolus BAP technique.

Sunekos 200 is HA combined with six amino acids (glycine, L-proline, L-lysine, L-leucine, L-valine, L-alanine) by Professional Derma. The active mechanism is fibroblast bio-stimulation; the amino-acid load functions as a substrate for collagen and elastin synthesis.

Indication overlap and difference

DimensionProfhiloSunekos 200
Primary indicationSkin laxity, face, neck, decolletageBio-stimulation, periorbital, perioral, neck
MechanismHybrid HA bio-remodellerHA plus amino-acid fibroblast substrate
Protocol2 sessions, 30 days apart3 sessions, 14 days apart
Pack1 pre-filled syringe, 2ml2 vials, 3ml each
OFAB trade priceEUR 89.43 ex VATEUR 97.56 ex VAT
Best forAdult skin-quality maintenancePeriorbital, fine-line, fibroblast targeting

When to choose Profhilo

  • Patient presents with skin laxity in face, neck, or decolletage.
  • Maintenance protocol for adult skin quality.
  • Two-session timeline preferred over three.
  • HA-bio-remodelling-first practitioner preference.

When to choose Sunekos 200

  • Periorbital indication (Profhilo is not the first-line periorbital choice).
  • Patient with fine lines and fibroblast-substrate need.
  • Three-session protocol acceptable.
  • Fibroblast bio-stimulation framing fits the patient conversation better than HA bio-remodelling.

When to layer both

The combined Profhilo plus Sunekos protocol is increasingly standard in Irish premium clinics. The two products work via separate mechanisms, so layering does not double-dose a single pathway. A typical sequence is Sunekos 200 (three sessions, fibroblast bio-stimulation) followed at week eight by Profhilo (two sessions, HA bio-remodelling). This is a six-month treatment plan rather than a single-product protocol; price the patient accordingly.

The mistake most clinics make is positioning Profhilo and Sunekos as substitutes. They are complements. Pricing them as a layered protocol unlocks a higher patient lifetime value than either alone.

Stock implication for the clinic

If you are stocking one, Profhilo gets the larger budget because the Irish patient-recognition is higher; Sunekos converts on the practitioner recommendation rather than the brand pull. If you are stocking both, hold a 60/40 ratio Profhilo to Sunekos by unit count. Adjust based on six-month patient-mix data.

Order links

Both products are in stock at Coolock and dispatch same day on weekday orders before 12:30. View Profhilo or view Sunekos 200. Trade pricing is released after practitioner verification.